ColoSense Multitarget Stool RNA Test Demonstrated High Sensitivity For Detection Of Colorectal Cancer And Advanced Adenoma, Study Finds

Healio (12/12, Burba) reports, “The ColoSense multitarget stool RNA test demonstrated high sensitivity for detection of colorectal cancer and advanced adenoma, notably in individuals aged 45 to 49 years, according to” a study. The findings were published in JAMA.